- Release Date: 10/09/24 09:51
- Summary: First patient enters into Open Label Extension study
- Price Sensitive: Yes
- Download Document 306.9KB
- Forums
- ASX - By Stock
- Ann: First patient enters into Open Label Extension study
DXB
dimerix limited
Add to My Watchlist
2.78%
!
52.5¢

Ann: First patient enters into Open Label Extension study
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
52.5¢ |
Change
-0.015(2.78%) |
Mkt cap ! $315.0M |
Open | High | Low | Value | Volume |
54.0¢ | 54.0¢ | 52.0¢ | $380.7K | 724.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 54189 | 52.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
52.5¢ | 4615 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 54189 | 0.520 |
6 | 60540 | 0.515 |
6 | 52489 | 0.510 |
6 | 166763 | 0.505 |
8 | 44112 | 0.500 |
Price($) | Vol. | No. |
---|---|---|
0.525 | 4615 | 2 |
0.530 | 17165 | 3 |
0.535 | 30066 | 4 |
0.540 | 98679 | 6 |
0.545 | 52448 | 4 |
Last trade - 11.18am 16/09/2025 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman and CEO
Hank Holland
Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online